Page last updated: 2024-11-08

serine and Cancer of Lung

serine has been researched along with Cancer of Lung in 113 studies

Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"Imaging of breast cancer cell lines revealed that WFA induces perinuclear vimentin accumulation followed by rapid vimentin depolymerization."5.37Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. ( Bender, L; Ganesh, T; Garcia, A; Harvey, RD; Kline, E; Liu, Y; Marcus, AI; Patel, P; Thaiparambil, JT; Tighiouart, M; Vertino, PM, 2011)
" Here, we revealed the mechanism by which skeletal protein Emerin (EMD) promoted glucose metabolism to induce lung adenocarcinoma (LUAD)."4.12ISGylation of EMD promotes its interaction with PDHA to inhibit aerobic oxidation in lung adenocarcinoma. ( Cao, L; Cui, J; Guo, W; Ma, L; Miao, Y; Qiu, S; Tian, X; Wang, Y; Xia, J; Zhang, C; Zhang, X, 2022)
"5-35 mg/m2) in combination with docetaxel (60 or 75 mg/m2) and cisplatin (75 mg/m2), agents were administered 24 h apart every 3 weeks to Japanese patients with advanced solid tumors."2.87Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors. ( Ecstein-Fraisse, E; Hida, T; Horiike, A; Horio, Y; Nishio, M; Satouchi, M; Sunaga, Y, 2018)
"Ganoderic acid is a triterpene from basiodiomycetes fungus Ganoderma lucidum with numerous therapeutic effects."1.46Ganoderic acid targeting nuclear factor erythroid 2-related factor 2 in lung cancer. ( Gill, BS; Kumar, S, 2017)
"Irinotecan has also displayed efficacy in clinical trials of NSCLC."1.42Topoisomerase-I PS506 as a Dual Function Cancer Biomarker. ( Gjerset, RA; Zhao, M, 2015)
"Our results define a role for PCK2 in cancer cell metabolic reprogramming that promotes glucose-independent cell growth and metabolic stress resistance in human tumors."1.42Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth. ( Artyomov, MN; Avizonis, D; Blagih, J; Bridon, G; Choinière, L; Coelho, PP; Elder, DJ; Flynn, BR; Gingras, MC; Griss, T; Jones, RG; Loginicheva, E; Ntimbane, T; Pause, A; Raissi, TC; Samborska, B; Sergushichev, A; Tavaré, JM; Thomas, EC; Vincent, EE, 2015)
"In addition, LY2603618-treated lung cancer cells transitioned from LC3-I to LC3-II, a hallmark of autophagy."1.40The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells. ( Cui, YJ; Fei, HR; Li, ZM; Sun, BL; Sun, YK; Wang, FZ; Wang, XY; Yang, XY; Zhang, JG, 2014)
"Cowden's syndrome is a rare autosomal dominant disorder that has been linked to germline mutations in the phosphatase and TENsin homolog (PTEN) gene."1.39Primary lung adenocarcinoma occurring in a PTEN related syndrome (Cowden's disease): routine EGFR sequencing also highlights two rare somatic mutations S768I and V769L. ( Boespflug, A; Bringuier, PP; Couraud, S; Durieu, I; Edery, P; Gérinière, L; Isaac, S; Perrot, E; Souquet, PJ, 2013)
"TICs from primary NSCLC tumors express high levels of the oncogenic stem cell factor LIN28B and GLDC, which are both required for TIC growth and tumorigenesis."1.38Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. ( Ahmed, DA; Ang, HS; Bhakoo, KK; Jayapal, SR; Kaldis, P; Lim, B; Lim, EH; Ma, S; Mitchell, W; Nga, ME; Nichane, M; Noghabi, MS; Pang, YH; Rai, A; Robson, P; Shyh-Chang, N; Sing, WP; Soh, BS; Soo, RA; Sun, LL; Swarup, S; Tai, BC; Tam, J; Tan, C; Thirugananam, A; Umashankar, S; Yang, H; Yu, Q; Zhang, WC, 2012)
"Imaging of breast cancer cell lines revealed that WFA induces perinuclear vimentin accumulation followed by rapid vimentin depolymerization."1.37Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. ( Bender, L; Ganesh, T; Garcia, A; Harvey, RD; Kline, E; Liu, Y; Marcus, AI; Patel, P; Thaiparambil, JT; Tighiouart, M; Vertino, PM, 2011)
"Although hyperoxia is known to cause DNA base modifications and strand breaks, the DNA damage response has not been adequately investigated."1.35Differential roles of ATR and ATM in p53, Chk1, and histone H2AX phosphorylation in response to hyperoxia: ATR-dependent ATM activation. ( Das, KC; Kulkarni, A, 2008)
" This combination effect was found over wide dosage ranges of AC-7700 (20-80 mg/kg) and CDDP (2."1.32Combination effect of AC-7700, a novel combretastatin A-4 derivative, and cisplatin against murine and human tumors in vivo. ( Ehara, S; Harada, K; Morinaga, Y; Nihei, Y; Suga, Y; Suzuki, M, 2003)
"Hyperoxia has been shown to cause DNA damage resulting in growth arrest of cells in p53-dependent, as well as p53-independent, pathways."1.32Hyperoxia activates the ATR-Chk1 pathway and phosphorylates p53 at multiple sites. ( Das, KC; Dashnamoorthy, R, 2004)

Research

Studies (113)

TimeframeStudies, this research(%)All Research%
pre-19907 (6.19)18.7374
1990's4 (3.54)18.2507
2000's34 (30.09)29.6817
2010's43 (38.05)24.3611
2020's25 (22.12)2.80

Authors

AuthorsStudies
Chen, P1
Qin, Z1
Sun, X5
Yang, J1
Lv, J1
Diao, M1
Huang, YL1
Chen, YJ1
Juan, YH1
Wu, SG1
Chung, KP1
He, L1
Endress, J1
Cho, S1
Li, Z4
Zheng, Y1
Asara, JM2
Blenis, J1
Chen, L1
Kang, Y1
Jiang, Y1
You, J1
Huang, C1
Xu, X1
Chen, F1
Li, L2
Li, P1
Ma, X1
Zeng, S2
Peng, Y2
Zhang, G2
Li, G1
Xu, Z2
Peng, J1
Yan, Y1
Liu, Y4
Zhang, X4
Qiu, Y1
Fu, C1
Du, W1
Wang, H1
Zhao, Y2
Huang, Z1
Zhang, C2
Cui, J2
Cao, L1
Tian, X1
Miao, Y1
Wang, Y4
Qiu, S1
Guo, W1
Ma, L1
Xia, J1
Faltus, C1
Lahnsteiner, A1
Barrdahl, M1
Assenov, Y1
Hüsing, A1
Bogatyrova, O1
Laplana, M1
Johnson, T1
Muley, T2
Meister, M1
Warth, A1
Thomas, M1
Plass, C1
Kaaks, R1
Risch, A2
Valencia, K1
Echepare, M1
Teijeira, Á1
Pasquier, A1
Bértolo, C1
Sainz, C1
Tamayo, I1
Picabea, B1
Bosco, G1
Thomas, R1
Agorreta, J1
López-Picazo, JM1
Frigola, J1
Amat, R1
Calvo, A1
Felip, E1
Melero, I1
Montuenga, LM1
Li, D1
Ding, Z1
Ai, R1
Shi, L1
Wang, Z1
He, Q1
Dong, Y1
Zhu, Y4
Ouyang, W1
He, Y3
Hao, D1
Li, Y2
Shi, J2
Jiang, J1
Xu, M3
Ding, L3
Yang, G3
Kong, J3
Chen, X4
Xu, L3
Shan, Y3
Xu, Y4
Grenda, A1
Krawczyk, P1
Targowska-Duda, KM1
Kieszko, R1
Paśnik, I1
Milanowski, J1
Heylen, E1
Verstraete, P1
Van Aerschot, L1
Geeraerts, SL1
Venken, T1
Timcheva, K1
Nittner, D1
Verbeeck, J1
Royaert, J1
Gijbels, M1
Uyttebroeck, A1
Segers, H1
Lambrechts, D1
Cools, J1
De Keersmaecker, K1
Kampen, KR1
Park, SM1
Seo, EH1
Bae, DH1
Kim, SS1
Kim, J1
Lin, W1
Kim, KH1
Park, JB1
Kim, YS1
Yin, J1
Kim, SY1
Volz, C1
Breid, S1
Selenz, C1
Zaplatina, A1
Golfmann, K1
Meder, L1
Dietlein, F1
Borchmann, S1
Chatterjee, S1
Siobal, M1
Schöttle, J1
Florin, A1
Koker, M1
Nill, M1
Ozretić, L1
Uhlenbrock, N1
Smith, S1
Büttner, R1
Miao, H1
Wang, B1
Reinhardt, HC1
Rauh, D1
Hallek, M1
Acker-Palmer, A1
Heukamp, LC1
Ullrich, RT1
Liu, J1
Wu, H1
Sun, XX1
Huang, S1
Yue, X1
Lu, SE1
Shen, Z1
Su, X1
White, E1
Haffty, BG1
Hu, W1
Feng, Z1
Tong, J1
Krieger, JR1
Taylor, P1
Bagshaw, R1
Kang, J1
Jeedigunta, S1
Wybenga-Groot, LE1
Zhang, W1
Badr, H1
Mirhadi, S1
Pham, NA1
Coyaud, É1
Yu, M1
Li, M1
Cabanero, M1
Raught, B1
Maynes, JT1
Hawkins, C1
Tsao, MS1
Moran, MF1
Krassikova, L1
Zhang, B2
Nagarajan, D1
Queiroz, AL1
Kacal, M1
Samakidis, E1
Vakifahmetoglu-Norberg, H2
Norberg, E2
Kim, YJ1
Kang, MJ1
Kim, E1
Kweon, TH1
Park, YS1
Ji, S1
Yang, WH1
Yi, EC1
Cho, JW1
Rinaldi, G1
Pranzini, E1
Van Elsen, J1
Broekaert, D1
Funk, CM1
Planque, M1
Doglioni, G1
Altea-Manzano, P1
Rossi, M1
Geldhof, V1
Teoh, ST1
Ross, C1
Hunter, KW1
Lunt, SY1
Grünewald, TGP1
Fendt, SM1
Lee, JH2
Yoo, SS1
Hong, MJ1
Choi, JE1
Kim, S1
Kang, HG1
Do, SK1
Kim, JH1
Baek, SA1
Lee, WK1
Do Yoo, J1
Choi, SH1
Lee, YH1
Seo, H1
Lee, J1
Lee, SY2
Cha, SI1
Kim, CH1
Park, JY1
Audet-Delage, Y1
St-Pierre, J1
Vaughan, CA1
Singh, S1
Subler, MA1
Windle, JJ1
Inoue, K2
Fry, EA1
Pillappa, R1
Grossman, SR2
Windle, B1
Andrew Yeudall, W1
Deb, SP1
Deb, S2
Broggi, G1
Angelico, G1
Filetti, V1
Ledda, C1
Lombardo, C1
Vitale, E1
Rapisarda, V1
Loreto, C1
Caltabiano, R1
Gill, BS1
Kumar, S1
Zheng, A1
Hydbring, P1
Ambroise, G1
Ouchida, AT1
Goiny, M1
Yao, K1
Peng, C1
Zhang, Y3
Zykova, TA1
Lee, MH1
Rao, E1
Chen, H1
Ryu, J1
Wang, L1
Gao, G1
He, W1
Ma, WY1
Liu, K1
Bode, AM1
Dong, Z2
Li, B1
Nishio, M1
Satouchi, M1
Horiike, A1
Horio, Y1
Sunaga, Y1
Ecstein-Fraisse, E1
Hida, T2
Tramonti, A2
Paiardini, A3
Paone, A3
Bouzidi, A2
Giardina, G3
Guiducci, G2
Magnifico, MC2
Rinaldo, S3
McDermott, L1
Menendez, JA1
Contestabile, R3
Cutruzzolà, F3
Lucchi, R1
Marani, M2
Pontecorvi, V1
Zamparelli, C1
Yang, B1
Wang, X1
Mu, Y1
Zhou, Y2
Li, W1
Zhou, L1
Lu, X2
Gao, P1
Gao, M1
Wang, Q1
Xu, G1
Shi, S1
Zhang, J1
Liu, M1
Dong, H1
Li, N1
Jeon, YH1
Park, YH1
Kwon, JH1
Kim, IY1
Yu, L1
Amelio, I1
Markert, EK1
Rufini, A1
Antonov, AV1
Sayan, BS1
Tucci, P1
Agostini, M1
Mineo, TC1
Levine, AJ1
Melino, G1
von Pawel, J1
Gorbounova, V1
Reck, M1
Kowalski, DM1
Allard, A1
Chadjaa, M1
Rey, A1
Bennouna, J1
Grossi, F1
Park, HR1
Shi, Z1
Pham, CD1
Du, Y1
Khuri, FR2
Han, Q1
Fu, H1
Krześniak, M1
Zajkowicz, A2
Matuszczyk, I1
Rusin, M2
Song, L1
Smith, MA1
Doshi, P1
Sasser, K1
Fulp, W1
Altiok, S1
Haura, EB1
Wang, FZ1
Fei, HR1
Cui, YJ1
Sun, YK1
Li, ZM1
Wang, XY1
Yang, XY1
Zhang, JG1
Sun, BL1
Xin, M1
Li, R1
Xie, M1
Park, D1
Owonikoko, TK1
Sica, GL1
Corsino, PE1
Zhou, J1
Ding, C1
White, MA1
Magis, AT1
Ramalingam, SS1
Curran, WJ1
Deng, X1
Fiascarelli, A1
Butkiewicz, D2
Drosik, A1
Giglok, M1
Suwiński, R1
Fukasawa, T1
Enomoto, A1
Miyagawa, K1
Yamada, N1
Tanaka, T2
Hori, T1
Yokoyama, S1
Hayakawa, Y1
Yano, S1
Fukuoka, J1
Koizumi, K1
Saiki, I1
Sakurai, H1
Zhao, M1
Gjerset, RA2
Hu, S1
Lu, Y1
Orr, B1
Godek, K1
Mustachio, LM1
Kawakami, M1
Sekula, D1
Compton, DA1
Freemantle, S1
Dmitrovsky, E1
Vincent, EE2
Sergushichev, A1
Griss, T1
Gingras, MC1
Samborska, B1
Ntimbane, T1
Coelho, PP1
Blagih, J1
Raissi, TC1
Choinière, L1
Bridon, G1
Loginicheva, E1
Flynn, BR1
Thomas, EC2
Tavaré, JM2
Avizonis, D1
Pause, A1
Elder, DJ2
Artyomov, MN1
Jones, RG1
DeNicola, GM1
Chen, PH1
Mullarky, E1
Sudderth, JA1
Hu, Z1
Wu, D1
Tang, H1
Xie, Y1
Huffman, KE1
Wistuba, II1
Minna, JD1
DeBerardinis, RJ1
Cantley, LC1
Frum, RA1
Love, IM1
Damle, PK1
Mukhopadhyay, ND1
Palit Deb, S1
Gao, X1
Feng, J1
Xu, F1
Fan, X1
Huang, W1
Xiong, H1
Liu, Q1
Liu, W1
Liu, X1
He, QY1
Zhang, Q1
Liu, L1
Kuang, XY1
Jiang, HS1
Li, K1
Zheng, YZ1
Liu, YR1
Qiao, F1
Li, S2
Hu, X1
Shao, ZM1
Riscal, R1
Schrepfer, E1
Arena, G1
Cissé, MY1
Bellvert, F1
Heuillet, M1
Rambow, F1
Bonneil, E1
Sabourdy, F1
Vincent, C1
Ait-Arsa, I1
Levade, T1
Thibaut, P1
Marine, JC1
Portais, JC1
Sarry, JE1
Le Cam, L1
Linares, LK1
Lukic, A1
Ji, J1
Idborg, H1
Samuelsson, B1
Palmberg, L1
Gabrielsson, S1
Rådmark, O1
Kreager, DA1
Ragan, DT1
Nguyen, H1
Staff, J1
Bartosh, TJ1
Ylostalo, JH1
Dutta, NK1
He, R1
Pinn, ML1
Burrows, F1
Zhang, ZY1
Karakousis, PC1
Jin, YJ1
Wang, S1
Cho, J1
Selim, MA1
Wright, T1
Mosialos, G1
Zhang, JY1
Roy, S1
Karmakar, T1
Nagappa, LK1
Prahlada Rao, VS1
Balasubramanian, S1
Balaram, H1
Mazuquin, BF1
Dela Bela, LF1
Pelegrinelli, AR1
Dias, JM1
Carregaro, RL1
Moura, FA1
Selfe, J1
Richards, J1
Brown, LE1
Cardoso, JR1
Naeem, MA1
Armutlulu, A1
Broda, M1
Lebedev, D1
Müller, CR1
Jin, X1
Liang, N1
Wang, M1
Meng, Y1
Jia, B1
Shi, X1
Luo, J1
Luo, Y1
Cui, Q1
Zheng, K1
Liu, Z1
Li, F1
Wang, F1
Zhu, Z1
Gallo, S1
Woolfrey, AE1
Burroughs, LM1
Storer, BE1
Flowers, ME1
Hari, P1
Pulsipher, MA1
Heimfeld, S1
Kiem, HP1
Sandmaier, BM1
Storb, R1
Cho, KJ1
Casteel, DE1
Prakash, P1
Tan, L1
van der Hoeven, D1
Salim, AA1
Kim, C1
Capon, RJ1
Lacey, E1
Cunha, SR1
Gorfe, AA1
Hancock, JF1
Ko, E1
Kim, Y1
Lee, BB1
Han, J1
Song, SY1
Shim, YM1
Park, J1
Kim, DH1
Yeh, HH1
Giri, R1
Chang, TY1
Chou, CY1
Su, WC1
Liu, HS1
Okasaka, T1
Matsuo, K1
Suzuki, T1
Ito, H1
Hosono, S1
Kawase, T1
Watanabe, M1
Yatabe, Y1
Mitsudomi, T1
Tanaka, H1
Yokoi, K1
Tajima, K2
Oh, HL1
Lee, DK1
Lim, H1
Lee, CH1
Yamada, C1
Ozaki, T1
Ando, K1
Suenaga, Y1
Ito, Y1
Okoshi, R1
Kageyama, H1
Kimura, H1
Miyazaki, M1
Nakagawara, A1
Zhang, PX1
Jiang, GY1
Li, QC1
Wang, EH1
Phillips, L1
Morgan, C1
Pawade, J1
Sohail, M1
May, MT1
Hetzel, MR1
Thaiparambil, JT1
Bender, L1
Ganesh, T1
Kline, E1
Patel, P1
Tighiouart, M1
Vertino, PM1
Harvey, RD1
Garcia, A1
Marcus, AI1
Zhang, WC1
Shyh-Chang, N1
Yang, H1
Rai, A1
Umashankar, S1
Ma, S1
Soh, BS1
Sun, LL1
Tai, BC1
Nga, ME1
Bhakoo, KK1
Jayapal, SR1
Nichane, M1
Yu, Q1
Ahmed, DA1
Tan, C1
Sing, WP1
Tam, J1
Thirugananam, A1
Noghabi, MS1
Pang, YH1
Ang, HS1
Mitchell, W1
Robson, P1
Kaldis, P1
Soo, RA1
Swarup, S1
Lim, EH1
Lim, B1
Assiddiq, BF1
Tan, KY1
Toy, W1
Chan, SP1
Chong, PK1
Lim, YP1
Rettig, M1
Trinidad, K1
Pezeshkpour, G1
Frost, P1
Sharma, S1
Moatamed, F1
Tamanoi, F1
Mortazavi, F1
Boespflug, A1
Couraud, S1
Bringuier, PP1
Isaac, S1
Gérinière, L1
Perrot, E1
Edery, P1
Durieu, I1
Souquet, PJ1
Su, L1
Liu, G1
Zhou, W1
Xu, LL1
Miller, DP1
Park, S1
Lynch, TJ1
Wain, JC1
Christiani, DC1
Morinaga, Y1
Suga, Y1
Ehara, S1
Harada, K1
Nihei, Y1
Suzuki, M1
Ding, H1
Duan, W1
Zhu, WG1
Ju, R1
Srinivasan, K1
Otterson, GA1
Villalona-Calero, MA1
Lillehoj, EP1
Han, F1
Kim, KC1
Holownia, A2
Mroz, RM2
Kozlowski, M1
Chyczewska, E2
Laudanski, J1
Chyczewski, L2
Braszko, JJ2
Das, KC2
Dashnamoorthy, R1
RYAN, WL1
LORINCZ, AB1
Hori, K2
Saito, S2
Kittiniyom, K1
Mastronardi, M1
Roemer, M1
Wells, WA1
Greenberg, ER1
Titus-Ernstoff, L1
Newsham, IF1
Ishii, T1
Fujishiro, M1
Masuda, M1
Goshima, Y1
Kitamura, H1
Teramoto, S1
Matsuse, T1
Yap, DB1
Hsieh, JK1
Zhong, S1
Heath, V1
Gusterson, B1
Crook, T1
Hung, RJ1
Brennan, P1
Canzian, F1
Szeszenia-Dabrowska, N1
Zaridze, D1
Lissowska, J1
Rudnai, P1
Fabianova, E1
Mates, D1
Foretova, L1
Janout, V1
Bencko, V1
Chabrier, A1
Borel, S1
Hall, J1
Boffetta, P1
Oleinik, NV1
Krupenko, NI1
Priest, DG1
Krupenko, SA1
Chen, G1
Bhojani, MS1
Heaford, AC1
Chang, DC1
Laxman, B1
Thomas, DG1
Griffin, LB1
Yu, J1
Coppola, JM1
Giordano, TJ1
Lin, L1
Adams, D1
Orringer, MB1
Ross, BD1
Beer, DG1
Rehemtulla, A1
Ichwan, SJ1
Yamada, S1
Sumrejkanchanakij, P1
Ibrahim-Auerkari, E1
Eto, K1
Ikeda, MA1
Besson, A1
Gurian-West, M1
Kelly-Spratt, KS1
Kemp, CJ1
Roberts, JM1
Gu, J1
Wu, X1
Dong, Q1
Romeo, MJ1
Lin, X1
Gutkind, JS1
Berman, DM1
Claudio, PP1
Ghafouri, M1
Mariano, C1
White, MK1
Safak, M1
Sheffield, JB1
Giordano, A1
Khalili, K1
Amini, S1
Sawaya, BE1
Scaglioni, PP1
Yung, TM1
Cai, LF1
Erdjument-Bromage, H1
Kaufman, AJ1
Singh, B1
Teruya-Feldstein, J1
Tempst, P1
Pandolfi, PP1
Sørensen, M2
Raaschou-Nielsen, O2
Hansen, RD1
Tjønneland, A2
Overvad, K2
Vogel, U2
Asahina, H1
Yamazaki, K1
Kinoshita, I1
Yokouchi, H1
Dosaka-Akita, H1
Nishimura, M3
Popanda, O1
Edler, L1
Waas, P1
Schattenberg, T1
Dienemann, H1
Bartsch, H1
Schmezer, P1
Yuan, BZ1
Jefferson, AM1
Millecchia, L1
Popescu, NC1
Reynolds, SH1
Bandyopadhyay, K1
Lee, C1
Haghighi, A1
Banères, JL1
Parello, J1
Hatt, L1
Loft, S1
Risom, L1
Møller, P1
Yamada, T1
Komoto, J1
Kasuya, T1
Takata, Y1
Ogawa, H1
Mori, H1
Takusagawa, F1
Kulkarni, A1
Wessel, I1
Jensen, PB1
Falck, J1
Mirski, SE1
Cole, SP1
Sehested, M1
Kohno, T2
Shinmura, K2
Tosaka, M1
Tani, M1
Kim, SR1
Sugimura, H2
Nohmi, T1
Kasai, H1
Yokota, J2
Kurian, MS1
de la Cuesta, RS1
Waneck, GL1
MacLaughlin, DT1
Manganaro, TF1
Donahoe, PK1
Wakai, K1
Nagura, K1
Genka, K1
Igarashi, H1
Morris, BJ1
Baba, S1
Ohno, Y1
Gao, C1
Wang, J1
Takezaki, T1
Varga, T1
Sawaguchi, T1
Lum, JK1
Martinson, JJ1
Tsugane, S1
Iwamasa, T1
Yang, CP1
Horwitz, SB1
Oda, K1
Arakawa, H1
Matsuda, K1
Tanikawa, C1
Mori, T1
Nishimori, H1
Tamai, K1
Tokino, T1
Nakamura, Y1
Taya, Y1
Le Marchand, L1
Donlon, T1
Lum-Jones, A1
Seifried, A1
Wilkens, LR1
Kubota, K1
Nakada, H2
Nakajima, H1
Hori, Y1
Ezaki, M1
Goto, T2
Okuhara, M2
Kawamura, I1
Mizota, T1
Shimomura, K1
Nakahara, K1
Yamaguchi, I1
Yue, XF1
Wu, FG1
Xu, B1
Fujita, M1
Taniguchi, N1
Makita, A1
Ono, M1
Oikawa, K1
Spellman, CM1
Fottrell, PF1
Wolberg, WH1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
An Open-label, Dose-escalation, Safety and Pharmacokinetics Phase I Study of Ombrabulin in Combination With Docetaxel and Cisplatin Every 3 Weeks in Patients With Advanced Solid Tumors[NCT01095302]Phase 111 participants (Actual)Interventional2010-05-31Completed
A Phase I Study to Determine the Efficacy and Safety of CKD-516 Tablet Combined With Durvalumab(MEDI4736) in Patient Refractory Solid Tumors[NCT04696848]Phase 1/Phase 225 participants (Actual)Interventional2021-02-24Terminated (stopped due to Recruitment difficulty)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for serine and Cancer of Lung

ArticleYear
Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in
    International journal of molecular sciences, 2023, Jan-07, Volume: 24, Issue:2

    Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Extracellular Signal-Regulated MAP K

2023
Association between the hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis based on 22,475 subjects.
    Diagnostic pathology, 2013, Aug-23, Volume: 8

    Topics: Chi-Square Distribution; DNA Glycosylases; Gene Frequency; Genetic Predisposition to Disease; Hetero

2013

Trials

3 trials available for serine and Cancer of Lung

ArticleYear
Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors.
    Japanese journal of clinical oncology, 2018, Apr-01, Volume: 48, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asian People; Ca

2018
DISRUPT: a randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane-platinum regimen as first-line therapy for metastatic non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2014, Volume: 85, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compoun

2014
No association between the p21 codon 31 serine-arginine polymorphism and lung cancer risk.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2003, Volume: 12, Issue:2

    Topics: Age Factors; Arginine; Case-Control Studies; Codon; Female; Genes, p53; Genetic Code; Genetic Marker

2003

Other Studies

108 other studies available for serine and Cancer of Lung

ArticleYear
Expression and Clinical Significance of lncRNA OSER1-AS1 in Peripheral Blood of Patients with Non-Small Cell Lung Cancer.
    Cells, tissues, organs, 2022, Volume: 211, Issue:5

    Topics: Carcinoma, Non-Small-Cell Lung; Chondroitin Sulfates; Gene Expression Regulation, Neoplastic; Humans

2022
Prognostic significance of dynamin-related protein 1 expression in advanced lung adenocarcinoma.
    Pathology, research and practice, 2022, Volume: 234

    Topics: Adenocarcinoma of Lung; Dynamins; ErbB Receptors; Humans; Lung Neoplasms; Mutation; Prognosis; Prote

2022
Suppression of nuclear GSK3 signaling promotes serine/one-carbon metabolism and confers metabolic vulnerability in lung cancer cells.
    Science advances, 2022, 05-20, Volume: 8, Issue:20

    Topics: Adaptor Proteins, Signal Transducing; Carbon; Glycogen Synthase Kinase 3; Humans; Lung Neoplasms; Pr

2022
Overexpression of SFXN1 indicates poor prognosis and promotes tumor progression in lung adenocarcinoma.
    Pathology, research and practice, 2022, Volume: 237

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carbon; Cell Line, Tumor; Cell Movement; Cell Proliferation;

2022
Therapeutic restoring p53 function with small molecule for oncogene-driven non-small cell lung cancer by targeting serine 392 phosphorylation.
    Biochemical pharmacology, 2022, Volume: 203

    Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Humans; Lung Neoplasms;

2022
The RIPK family: expression profile and prognostic value in lung adenocarcinoma.
    Aging, 2022, 07-30, Volume: 14, Issue:14

    Topics: Adenocarcinoma of Lung; Biomarkers, Tumor; Disease-Free Survival; Humans; Lung Neoplasms; Prognosis;

2022
Small-molecule MX-C2/3 suppresses non-small cell lung cancer progression via p53 activation.
    Chemico-biological interactions, 2022, Oct-01, Volume: 366

    Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neopla

2022
ISGylation of EMD promotes its interaction with PDHA to inhibit aerobic oxidation in lung adenocarcinoma.
    Journal of cellular and molecular medicine, 2022, Volume: 26, Issue:19

    Topics: Adenocarcinoma of Lung; beta Catenin; Glucose; Humans; Lung Neoplasms; Lysine; Membrane Proteins; Nu

2022
Identification of
    International journal of molecular sciences, 2022, Sep-14, Volume: 23, Issue:18

    Topics: Biomarkers; CpG Islands; DNA Methylation; Epigenesis, Genetic; Epigenome; Genome-Wide Association St

2022
DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity.
    The Journal of experimental medicine, 2022, 12-05, Volume: 219, Issue:12

    Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Receptor-Interacting Protein Serine-Threonin

2022
Identification and Exploration of Serine Peptidase Inhibitor Kazal Type I (SPINK1) as a Potential Biomarker Correlated with the Progression of Non-Small Cell Lung Cancer.
    Cell biochemistry and biophysics, 2022, Volume: 80, Issue:4

    Topics: Biomarkers; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Gene Expression Re

2022
Bioinformatic Analysis Identifies of Potential miRNA-mRNA Regulatory Networks Involved in the Pathogenesis of Lung Cancer.
    Computational intelligence and neuroscience, 2022, Volume: 2022

    Topics: Biomarkers; Computational Biology; Gene Expression Profiling; Gene Expression Regulation, Neoplastic

2022
The amino acid and carnitine concentration changes in bronchoalveolar lavage fluid from lung cancer patients.
    World journal of surgical oncology, 2022, Dec-04, Volume: 20, Issue:1

    Topics: Amino Acids; Bronchoalveolar Lavage Fluid; Carnitine; Humans; Lung Neoplasms; Serine

2022
The amino acid and carnitine concentration changes in bronchoalveolar lavage fluid from lung cancer patients.
    World journal of surgical oncology, 2022, Dec-04, Volume: 20, Issue:1

    Topics: Amino Acids; Bronchoalveolar Lavage Fluid; Carnitine; Humans; Lung Neoplasms; Serine

2022
The amino acid and carnitine concentration changes in bronchoalveolar lavage fluid from lung cancer patients.
    World journal of surgical oncology, 2022, Dec-04, Volume: 20, Issue:1

    Topics: Amino Acids; Bronchoalveolar Lavage Fluid; Carnitine; Humans; Lung Neoplasms; Serine

2022
The amino acid and carnitine concentration changes in bronchoalveolar lavage fluid from lung cancer patients.
    World journal of surgical oncology, 2022, Dec-04, Volume: 20, Issue:1

    Topics: Amino Acids; Bronchoalveolar Lavage Fluid; Carnitine; Humans; Lung Neoplasms; Serine

2022
Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer.
    British journal of cancer, 2023, Volume: 128, Issue:10

    Topics: Animals; Cell Line; Cell Line, Tumor; Glycine; Humans; Lung Neoplasms; Mice; Serine; Thyroid Nuclear

2023
Phosphoserine Phosphatase Promotes Lung Cancer Progression through the Dephosphorylation of IRS-1 and a Noncanonical L-Serine-Independent Pathway.
    Molecules and cells, 2019, Aug-31, Volume: 42, Issue:8

    Topics: A549 Cells; Animals; Disease Progression; Humans; Insulin Receptor Substrate Proteins; Lung Neoplasm

2019
Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC.
    Cell reports, 2020, 04-28, Volume: 31, Issue:4

    Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis;

2020
Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression.
    The Journal of clinical investigation, 2020, 06-01, Volume: 130, Issue:6

    Topics: A549 Cells; Animals; Breast Neoplasms; Female; Humans; Lung Neoplasms; MCF-7 Cells; Mice; Mice, Inbr

2020
Cancer proteome and metabolite changes linked to SHMT2.
    PloS one, 2020, Volume: 15, Issue:9

    Topics: Animals; Antifungal Agents; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Gene Expression Regula

2020
The deubiquitinase JOSD2 is a positive regulator of glucose metabolism.
    Cell death and differentiation, 2021, Volume: 28, Issue:3

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Endopeptidases; Femal

2021
O-GlcNAc stabilizes SMAD4 by inhibiting GSK-3β-mediated proteasomal degradation.
    Scientific reports, 2020, 11-16, Volume: 10, Issue:1

    Topics: Acetylglucosamine; Breast Neoplasms; Female; Glycogen Synthase Kinase 3 beta; Humans; Lung Neoplasms

2020
In Vivo Evidence for Serine Biosynthesis-Defined Sensitivity of Lung Metastasis, but Not of Primary Breast Tumors, to mTORC1 Inhibition.
    Molecular cell, 2021, 01-21, Volume: 81, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Prolif

2021
Impact of immune checkpoint gene CD155 Ala67Thr and CD226 Gly307Ser polymorphisms on small cell lung cancer clinical outcome.
    Scientific reports, 2021, 01-19, Volume: 11, Issue:1

    Topics: Aged; Alanine; Amino Acid Substitution; Antigens, Differentiation, T-Lymphocyte; Carcinoma, Small Ce

2021
Food for Growth: Distinct Nutrient Preferences between Primary Tumors and Metastases.
    Molecular cell, 2021, 01-21, Volume: 81, Issue:2

    Topics: Breast Neoplasms; Humans; Lung Neoplasms; Mechanistic Target of Rapamycin Complex 1; Nutrients; Seri

2021
The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3.
    Nature communications, 2021, 01-29, Volume: 12, Issue:1

    Topics: Animals; Carcinogenesis; Cell Line, Tumor; Disease Models, Animal; Female; Gain of Function Mutation

2021
Immunohistochemical Expression of Serine and Arginine-Rich Splicing Factor 1 (SRSF1) in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Study.
    International journal of environmental research and public health, 2021, 06-09, Volume: 18, Issue:12

    Topics: Arginine; Asbestos, Amphibole; Biomarkers, Tumor; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma

2021
Ganoderic acid targeting nuclear factor erythroid 2-related factor 2 in lung cancer.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:3

    Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cysteine; Humans; Lung Neoplasms

2017
PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis.
    Cell reports, 2017, 06-13, Volume: 19, Issue:11

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Cell Line, Tumor; Cell Proliferation; DNA, Neoplasm

2017
RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 11-28, Volume: 114, Issue:48

    Topics: Animals; Bone Marrow Transplantation; Colonic Neoplasms; Female; Gene Expression Regulation, Neoplas

2017
Differential inhibitory effect of a pyrazolopyran compound on human serine hydroxymethyltransferase-amino acid complexes.
    Archives of biochemistry and biophysics, 2018, 09-01, Volume: 653

    Topics: Apoptosis; Cell Line, Tumor; Enzyme Inhibitors; Glycine; Glycine Hydroxymethyltransferase; Humans; H

2018
The catalytic activity of serine hydroxymethyltransferase is essential for de novo nuclear dTMP synthesis in lung cancer cells.
    The FEBS journal, 2018, Volume: 285, Issue:17

    Topics: Cell Nucleus; Cell Proliferation; Crystallography, X-Ray; Glycine Hydroxymethyltransferase; Humans;

2018
A serine in exon 11 determines the full transcriptional activity of TCF-4 in lung carcinoma cells.
    Biochemical and biophysical research communications, 2019, 01-15, Volume: 508, Issue:3

    Topics: Animals; Base Sequence; Cell Line, Tumor; Cell Proliferation; Exons; Gene Expression Regulation, Neo

2019
Serum Metabolomics Study of Nonsmoking Female Patients with Non-Small Cell Lung Cancer Using Gas Chromatography-Mass Spectrometry.
    Journal of proteome research, 2019, 05-03, Volume: 18, Issue:5

    Topics: Adult; Aged; Amino Acids; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; C

2019
Ras-ERK signalling represses H1.4 phosphorylation at serine 36 to promote non-small-cell lung carcinoma cells growth and migration.
    Artificial cells, nanomedicine, and biotechnology, 2019, Volume: 47, Issue:1

    Topics: A549 Cells; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Cyclic AMP-Dependent

2019
Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W.
    Biochimica et biophysica acta, 2013, Volume: 1833, Issue:10

    Topics: 14-3-3 Proteins; Blotting, Western; Breast Neoplasms; Carrier Proteins; Cell Proliferation; Flow Cyt

2013
p73 regulates serine biosynthesis in cancer.
    Oncogene, 2014, Oct-16, Volume: 33, Issue:42

    Topics: Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Gene Expression Regulation, Enzymologic;

2014
Pro-oncogenic function of HIP-55/Drebrin-like (DBNL) through Ser269/Thr291-phospho-sensor motifs.
    Oncotarget, 2014, May-30, Volume: 5, Issue:10

    Topics: 14-3-3 Proteins; Adenocarcinoma; Amino Acid Motifs; Animals; Apoptosis; Blotting, Western; Cell Line

2014
Rapamycin prevents strong phosphorylation of p53 on serine 46 and attenuates activation of the p53 pathway in A549 lung cancer cells exposed to actinomycin D.
    Mechanisms of ageing and development, 2014, Volume: 139

    Topics: Aging; Antibiotics, Antineoplastic; Cell Line, Tumor; Dactinomycin; Humans; Lung Neoplasms; Nuclear

2014
Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014, Volume: 9, Issue:7

    Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chem

2014
The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells.
    Apoptosis : an international journal on programmed cell death, 2014, Volume: 19, Issue:9

    Topics: Antineoplastic Agents; Antirheumatic Agents; Autophagy; Carcinoma, Non-Small-Cell Lung; Caspases; Ce

2014
Small-molecule Bax agonists for cancer therapy.
    Nature communications, 2014, Sep-17, Volume: 5

    Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Binding Sites; Cell Line; Cel

2014
SHMT1 knockdown induces apoptosis in lung cancer cells by causing uracil misincorporation.
    Cell death & disease, 2014, Nov-20, Volume: 5

    Topics: Adenocarcinoma; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Gene Expression Regulation, Neo

2014
Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients.
    British journal of cancer, 2015, Mar-17, Volume: 112, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Codon, Nonsense; DNA Damage; DNA, Ne

2015
Serine-Threonine Kinase 38 regulates CDC25A stability and the DNA damage-induced G2/M checkpoint.
    Cellular signalling, 2015, Volume: 27, Issue:8

    Topics: cdc25 Phosphatases; Cell Line, Tumor; DNA Damage; Enzyme Activation; Enzyme Stability; G2 Phase Cell

2015
Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2.
    Nature communications, 2015, Jul-09, Volume: 6

    Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Catalysis; Cell Line, Tumor; Cell Movement; Cytoki

2015
Topoisomerase-I PS506 as a Dual Function Cancer Biomarker.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Amino Acid Sequence; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Camptothecin; Carcinoma,

2015
Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition: Evidence for Cooperation with USP33 Knockdown.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:11

    Topics: Anaphase; Animals; Binding Sites; Cell Cycle Proteins; Cell Line, Tumor; Centrosome; Cyclin-Dependen

2015
Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.
    Molecular cell, 2015, Oct-15, Volume: 60, Issue:2

    Topics: Adaptation, Physiological; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Prolifera

2015
NRF2 regulates serine biosynthesis in non-small cell lung cancer.
    Nature genetics, 2015, Volume: 47, Issue:12

    Topics: Adenocarcinoma; Animals; Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma, Non-Small-Cell

2015
Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination.
    Molecular cancer research : MCR, 2016, Volume: 14, Issue:5

    Topics: Ataxia Telangiectasia Mutated Proteins; Cell Line, Tumor; DNA Damage; Gene Expression Regulation, Ne

2016
hnRNPK inhibits GSK3β Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells.
    Scientific reports, 2016, Mar-14, Volume: 6

    Topics: Adenocarcinoma; Apoptosis; Blotting, Western; CASP8 and FADD-Like Apoptosis Regulating Protein; Casp

2016
The phosphorylation-specific association of STMN1 with GRP78 promotes breast cancer metastasis.
    Cancer letters, 2016, 07-10, Volume: 377, Issue:1

    Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Decision Support Tech

2016
Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53.
    Molecular cell, 2016, 06-16, Volume: 62, Issue:6

    Topics: Activating Transcription Factor 4; Animals; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell P

2016
Pulmonary epithelial cancer cells and their exosomes metabolize myeloid cell-derived leukotriene C4 to leukotriene D4.
    Journal of lipid research, 2016, Volume: 57, Issue:9

    Topics: A549 Cells; Arachidonate 5-Lipoxygenase; Borates; Eosinophils; Epithelial Cells; Exosomes; gamma-Glu

2016
    Journal of developmental and life-course criminology, 2016, Volume: 2, Issue:2

    Topics: Adolescent; Adult; Age Factors; Aged; Amino Acid Substitution; Anemia, Aplastic; Athletes; Athletic

2016
AMPK and Endothelial Nitric Oxide Synthase Signaling Regulates K-Ras Plasma Membrane Interactions via Cyclic GMP-Dependent Protein Kinase 2.
    Molecular and cellular biology, 2016, 12-15, Volume: 36, Issue:24

    Topics: AMP-Activated Protein Kinases; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor;

2016
Relationship of phospho-pRb (Ser-807/811) level to exposure to tobacco smoke in primary non-small cell lung cancer.
    Cancer letters, 2009, Feb-18, Volume: 274, Issue:2

    Topics: Carcinoma, Non-Small-Cell Lung; DNA Methylation; Female; Humans; Immunohistochemistry; Lung Neoplasm

2009
Ha-ras oncogene-induced Stat3 phosphorylation enhances oncogenicity of the cell.
    DNA and cell biology, 2009, Volume: 28, Issue:3

    Topics: Amino Acid Sequence; Animals; Apoptosis; Cell Line, Tumor; Cell Transformation, Neoplastic; Cyclin D

2009
hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type.
    Journal of human genetics, 2009, Volume: 54, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Case-Control Studies;

2009
HY253, a novel decahydrofluorene analog, from Aralia continentalis, induces cell cycle arrest at the G1 phase and cytochrome c-mediated apoptosis in human lung cancer A549 cells.
    Journal of ethnopharmacology, 2010, May-04, Volume: 129, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Aralia; Blotting, Western; Caspases; Cell Cycle Protei

2010
RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53.
    The Journal of biological chemistry, 2010, May-28, Volume: 285, Issue:22

    Topics: Adenocarcinoma; Apoptosis; Cell Line, Tumor; Core Binding Factor Alpha 3 Subunit; DNA Damage; Gene E

2010
p120-catenin isoform 3 regulates subcellular localization of Kaiso and promotes invasion in lung cancer cells via a phosphorylation-dependent mechanism.
    International journal of oncology, 2011, Volume: 38, Issue:6

    Topics: Active Transport, Cell Nucleus; Amino Acid Substitution; Animals; Catenins; Cell Line, Tumor; Delta

2011
Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer.
    British journal of cancer, 2011, May-24, Volume: 104, Issue:11

    Topics: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Enzyme Activation; Female; Humans; Lung Neoplasms

2011
Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation.
    International journal of cancer, 2011, Dec-01, Volume: 129, Issue:11

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Cell Differentiation; Cell Line

2011
Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis.
    Cell, 2012, Jan-20, Volume: 148, Issue:1-2

    Topics: Amino Acid Sequence; Antigens, CD; Carcinoma, Non-Small-Cell Lung; Cell Adhesion Molecules, Neuronal

2012
EGFR S1166 phosphorylation induced by a combination of EGF and gefitinib has a potentially negative impact on lung cancer cell growth.
    Journal of proteome research, 2012, Aug-03, Volume: 11, Issue:8

    Topics: Amino Acid Motifs; Amino Acid Sequence; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation;

2012
PAK1 kinase promotes cell motility and invasiveness through CRK-II serine phosphorylation in non-small cell lung cancer cells.
    PloS one, 2012, Volume: 7, Issue:7

    Topics: Carcinoma, Non-Small-Cell Lung; Catenins; Cell Line, Tumor; Cell Movement; Delta Catenin; Gene Expre

2012
Primary lung adenocarcinoma occurring in a PTEN related syndrome (Cowden's disease): routine EGFR sequencing also highlights two rare somatic mutations S768I and V769L.
    Lung cancer (Amsterdam, Netherlands), 2013, Volume: 79, Issue:3

    Topics: Adenocarcinoma; Adult; Chromosome Disorders; Diagnosis, Differential; DNA Mutational Analysis; ErbB

2013
Combination effect of AC-7700, a novel combretastatin A-4 derivative, and cisplatin against murine and human tumors in vivo.
    Cancer science, 2003, Volume: 94, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cisplatin; Col

2003
P21 response to DNA damage induced by genistein and etoposide in human lung cancer cells.
    Biochemical and biophysical research communications, 2003, Jun-13, Volume: 305, Issue:4

    Topics: Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Division; C

2003
Mutagenesis of a Gly-Ser cleavage site in MUC1 inhibits ectodomain shedding.
    Biochemical and biophysical research communications, 2003, Aug-01, Volume: 307, Issue:3

    Topics: Amino Acid Sequence; Animals; Breast Neoplasms; COS Cells; Glycine; Humans; Lung Neoplasms; Mice; Mu

2003
Therapy increases poly-ADP-ribose and p53-Ser392-P levels in recurrent squamous cell lung cancer.
    Neoplasma, 2003, Volume: 50, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cisplatin; C

2003
Hyperoxia activates the ATR-Chk1 pathway and phosphorylates p53 at multiple sites.
    American journal of physiology. Lung cellular and molecular physiology, 2004, Volume: 286, Issue:1

    Topics: Adenocarcinoma; Androstadienes; Ataxia Telangiectasia Mutated Proteins; Caffeine; Cell Cycle Protein

2004
FREE AMINO ACIDS OF HUMAN BREAST CANCER.
    The Nebraska state medical journal, 1964, Volume: 49

    Topics: Amino Acids; Asparagine; Aspartic Acid; Breast Neoplasms; Chromatography; Citrulline; Glutamates; Gl

1964
Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis.
    British journal of cancer, 2003, Oct-06, Volume: 89, Issue:7

    Topics: Animals; Arterioles; Blood Flow Velocity; Blood Pressure; Lung Neoplasms; Male; Microcirculation; Mu

2003
p53 N-terminal Ser-15 approximately P and Ser-20 approximately P levels in squamous cell lung cancer after radio/chemotherapy.
    American journal of respiratory cell and molecular biology, 2004, Volume: 30, Issue:4

    Topics: Aged; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; DNA Damage; Humans; Ki-67 Anti

2004
Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
    Genes, chromosomes & cancer, 2004, Volume: 40, Issue:3

    Topics: Adult; Alanine; Alleles; Amino Acid Sequence; Amino Acid Substitution; Animals; Base Sequence; Breas

2004
Effects of p27Kip1 on cell cycle status and viability in A549 lung adenocarcinoma cells.
    The European respiratory journal, 2004, Volume: 23, Issue:5

    Topics: Adenocarcinoma; Amino Acid Substitution; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Line; Cell

2004
Ser392 phosphorylation regulates the oncogenic function of mutant p53.
    Cancer research, 2004, Jul-15, Volume: 64, Issue:14

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor;

2004
Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study.
    Journal of the National Cancer Institute, 2005, Apr-20, Volume: 97, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Arginine; Case-Control Studies; Confounding Factors, Epidemiologic; Cys

2005
Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression.
    The Biochemical journal, 2005, Nov-01, Volume: 391, Issue:Pt 3

    Topics: Adenosine Triphosphate; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Gene Expression;

2005
Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas.
    Proceedings of the National Academy of Sciences of the United States of America, 2005, Aug-30, Volume: 102, Issue:35

    Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Apoptosis; Cell Cycle; Cell Nucleus; Cell Prol

2005
Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells.
    Oncogene, 2006, Feb-23, Volume: 25, Issue:8

    Topics: Adenoviridae; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Humans; Lung Neop

2006
A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression.
    Genes & development, 2006, Jan-01, Volume: 20, Issue:1

    Topics: Amino Acid Substitution; Animals; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dep

2006
A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans.
    Cancer, 2006, Jun-15, Volume: 106, Issue:12

    Topics: Aged; Alleles; Case-Control Studies; Cell Transformation, Neoplastic; Cyclin D1; DNA, Neoplasm; Fema

2006
Cdk9 phosphorylates p53 on serine 392 independently of CKII.
    Journal of cellular physiology, 2006, Volume: 208, Issue:3

    Topics: Brain Neoplasms; Casein Kinase II; Cell Line, Tumor; Cyclin-Dependent Kinase 9; Glioblastoma; HIV-1;

2006
A CK2-dependent mechanism for degradation of the PML tumor suppressor.
    Cell, 2006, Jul-28, Volume: 126, Issue:2

    Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Ca

2006
Interactions between the OGG1 Ser326Cys polymorphism and intake of fruit and vegetables in relation to lung cancer.
    Free radical research, 2006, Volume: 40, Issue:8

    Topics: Cysteine; Diet; DNA Glycosylases; Female; Fruit; Genetic Predisposition to Disease; Humans; Lung Neo

2006
Non-responsiveness to gefitinib in a patient with lung adenocarcinoma having rare EGFR mutations S768I and V769L.
    Lung cancer (Amsterdam, Netherlands), 2006, Volume: 54, Issue:3

    Topics: Adenocarcinoma; DNA, Neoplasm; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Isoleuc

2006
Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
    Lung cancer (Amsterdam, Netherlands), 2007, Volume: 55, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Carcinoma, Squamo

2007
Morphological changes and nuclear translocation of DLC1 tumor suppressor protein precede apoptosis in human non-small cell lung carcinoma cells.
    Experimental cell research, 2007, Nov-01, Volume: 313, Issue:18

    Topics: Actins; Amino Acid Sequence; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movem

2007
Serine phosphorylation-dependent coregulation of topoisomerase I by the p14ARF tumor suppressor.
    Biochemistry, 2007, Dec-11, Volume: 46, Issue:49

    Topics: Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; DNA Damage; DNA Topoisomerases, Type

2007
OGG1 expression and OGG1 Ser326Cys polymorphism and risk of lung cancer in a prospective study.
    Mutation research, 2008, Mar-01, Volume: 639, Issue:1-2

    Topics: Amino Acid Substitution; Case-Control Studies; Cohort Studies; Cysteine; DNA Glycosylases; DNA Repai

2008
A catalytic mechanism that explains a low catalytic activity of serine dehydratase like-1 from human cancer cells: crystal structure and site-directed mutagenesis studies.
    Biochimica et biophysica acta, 2008, Volume: 1780, Issue:5

    Topics: Amino Acid Substitution; Catalysis; Catalytic Domain; Cell Line, Tumor; Crystallography, X-Ray; Huma

2008
Differential roles of ATR and ATM in p53, Chk1, and histone H2AX phosphorylation in response to hyperoxia: ATR-dependent ATM activation.
    American journal of physiology. Lung cellular and molecular physiology, 2008, Volume: 294, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Apoptosis; Ataxia Telangiectasia Mutated Prote

2008
Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.
    Cancer research, 1997, Oct-15, Volume: 57, Issue:20

    Topics: Amino Acid Sequence; Amino Acid Substitution; Antigens, Neoplasm; ATP Binding Cassette Transporter,

1997
Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA.
    Oncogene, 1998, Jun-25, Volume: 16, Issue:25

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Alleles; Alternative Splicing; Cell Line; Codon; Cysteine; Deoxyguanosi

1998
Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:3

    Topics: Animals; Anti-Mullerian Hormone; Arginine; Cell Division; Eye Neoplasms; Female; Fibrinolysin; Glyco

1995
hOGG1 Ser326Cys polymorphism and lung cancer susceptibility.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1999, Volume: 8, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Carcinoma, Squamous Cell; Case-Control Studies; Cysteine; D

1999
Taxol mediates serine phosphorylation of the 66-kDa Shc isoform.
    Cancer research, 2000, Sep-15, Volume: 60, Issue:18

    Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Antineoplastic Agents,

2000
p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53.
    Cell, 2000, Sep-15, Volume: 102, Issue:6

    Topics: Adenocarcinoma; Animals; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Carcinoma, Non-

2000
Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2002, Volume: 11, Issue:4

    Topics: Adolescent; Adult; Aged; Amino Acid Substitution; Asian People; Case-Control Studies; Cysteine; Diet

2002
A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs.
    British journal of cancer, 2002, May-20, Volume: 86, Issue:10

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma; Drug Screening Assays, Antitumor; Heart Neopl

2002
A new antitumor antibiotic, FR900840. I. Discovery, identification, isolation and characterization.
    The Journal of antibiotics, 1989, Volume: 42, Issue:4

    Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Female; Fermentation; Humans

1989
A new antitumor antibiotic, FR900840. III. Antitumor activity against experimental tumors.
    The Journal of antibiotics, 1989, Volume: 42, Issue:4

    Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Carcinoma, Squamous Cel

1989
[Effect of oxalysine on pulmonary metastases of Lewis lung carcinoma in mice].
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1985, Volume: 6, Issue:3

    Topics: Amino Acids, Dicarboxylic; Animals; Antibiotics, Antineoplastic; Lung Neoplasms; Mice; Mice, Inbred

1985
Protein phosphorylation of beta-glucuronidase in human lung cancer--identification of serine- and threonine-phosphates.
    Biochemical and biophysical research communications, 1985, Jan-31, Volume: 126, Issue:2

    Topics: Adenocarcinoma; Chemical Phenomena; Chemistry; Electrophoresis, Polyacrylamide Gel; Glucuronidase; H

1985
Similarities between pyruvate kinase from human placenta and tumours.
    FEBS letters, 1973, Dec-01, Volume: 37, Issue:2

    Topics: Adenosine Triphosphate; Alanine; Carcinoma; Chromatography, Gel; Chromatography, Ion Exchange; Elect

1973
Response of DNA thymine synthesis in human tumor and normal tissue to 5-fluorouracil.
    Cancer research, 1972, Volume: 32, Issue:1

    Topics: Breast Neoplasms; Carbon Isotopes; Chromatography, Paper; Colon; Colonic Neoplasms; Depression, Chem

1972